247 related articles for article (PubMed ID: 25443894)
1. Incidence and management of extended-spectrum beta-lactamase and quinolone-resistant Escherichia coli infections after prostate biopsy.
Song W; Choo SH; Sung HH; Han DH; Jeong BC; Seo SI; Jeon SS; Lee KS; Lee SW; Lee HM; Choi HY; Jeon HG
Urology; 2014 Nov; 84(5):1001-7. PubMed ID: 25443894
[TBL] [Abstract][Full Text] [Related]
2. Incidence of acute prostatitis caused by extended-spectrum beta-lactamase-producing Escherichia coli after transrectal prostate biopsy.
Ozden E; Bostanci Y; Yakupoglu KY; Akdeniz E; Yilmaz AF; Tulek N; Sarikaya S
Urology; 2009 Jul; 74(1):119-23. PubMed ID: 19464043
[TBL] [Abstract][Full Text] [Related]
3. Positive culture for extended-spectrum β-lactamase during acute prostatitis after prostate biopsy is a risk factor for progression to chronic prostatitis.
Oh MM; Chae JY; Kim JW; Kim JW; Yoon CY; Park MG; Moon du G
Urology; 2013 Jun; 81(6):1209-12. PubMed ID: 23601450
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of fluoroquinolone-resistant Escherichia coli before and incidence of acute bacterial prostatitis after prostate biopsy.
Minamida S; Satoh T; Tabata K; Kimura M; Tsumura H; Kurosaka S; Matsumoto K; Fujita T; Iwamura M; Baba S
Urology; 2011 Dec; 78(6):1235-9. PubMed ID: 21908030
[TBL] [Abstract][Full Text] [Related]
5. Impact of selective media for detecting fluoroquinolone-insusceptible/extended-spectrum beta-lactamase-producing Escherichia coli before transrectal prostate biopsy.
Sadahira T; Wada K; Araki M; Ishii A; Watanabe T; Nasu Y; Tsugawa M; Takenaka T; Nasu Y; Kumon H
Int J Urol; 2017 Dec; 24(12):842-847. PubMed ID: 28929546
[TBL] [Abstract][Full Text] [Related]
6. Re: Incidence and Management of Extended-Spectrum Beta-Lactamase and Quinolone-Resistant Escherichia coli Infections after Prostate Biopsy.
Schaeffer EM
J Urol; 2015 Jul; 194(1):136. PubMed ID: 26088230
[No Abstract] [Full Text] [Related]
7. The real practice of antibiotic prophylaxis for prostate biopsy in Korea where the prevalence of quinolone-resistant Escherichia coli is high.
Kim DH; Bae SR; Choi WS; Park HK; Paick SH; Kim HG; Loh YS
Korean J Urol; 2014 Sep; 55(9):593-8. PubMed ID: 25237461
[TBL] [Abstract][Full Text] [Related]
8. Acute bacterial prostatitis after transrectal ultrasound-guided prostate biopsy: epidemiological, bacteria and treatment patterns from a 4-year prospective study.
Campeggi A; Ouzaid I; Xylinas E; Lesprit P; Hoznek A; Vordos D; Abbou CC; Salomon L; de la Taille A
Int J Urol; 2014 Feb; 21(2):152-5. PubMed ID: 23906113
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and characteristics of fecal antimicrobial-resistant Escherichia coli in a cohort of Japanese men undergoing prostate biopsy.
Kamei J; Yagihara Y; Kume H; Horiuchi T; Sato T; Nakagawa T; Fujimura T; Fukuhara H; Moriya K; Homma Y
Int J Urol; 2017 Apr; 24(4):295-300. PubMed ID: 28222483
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of fecal carriage of extended-spectrum β-lactamase after transrectal ultrasound-guided biopsy of the prostate.
Tukenmez Tigen E; Tandogdu Z; Ergonul O; Altinkanat G; Gunaydin B; Ozgen M; Sariguzel N; Erturk Sengel B; Odabasi Z; Cek M; Tokuc R; Turkeri L; Mulazimoglu L; Korten V
Urology; 2014 Nov; 84(5):1008-15. PubMed ID: 25239255
[TBL] [Abstract][Full Text] [Related]
11. Clinical and microbiological characteristics of spontaneous acute prostatitis and transrectal prostate biopsy-related acute prostatitis: Is transrectal prostate biopsy-related acute prostatitis a distinct acute prostatitis category?
Kim JW; Oh MM; Bae JH; Kang SH; Park HS; Moon du G
J Infect Chemother; 2015 Jun; 21(6):434-7. PubMed ID: 25701308
[TBL] [Abstract][Full Text] [Related]
12. Extended-spectrum β-lactamase in the rectal flora of patients undergoing transrectal prostate biopsy: a study of the prevalence in a major metropolitan hospital.
Sewell J; Chow K; De Sousa A; Sapre N; Norris B; Namdarian B; Sinickas V; Huang JG; Anderson P
BJU Int; 2019 May; 123 Suppl 5():43-46. PubMed ID: 31012990
[TBL] [Abstract][Full Text] [Related]
13. Risk Factor Analysis of Ciprofloxacin-Resistant and Extended Spectrum Beta-Lactamases Pathogen-Induced Acute Bacterial Prostatitis in Korea.
Lee Y; Lee DG; Lee SH; Yoo KH
J Korean Med Sci; 2016 Nov; 31(11):1808-1813. PubMed ID: 27709861
[TBL] [Abstract][Full Text] [Related]
14. Incidence of fluoroquinolone-resistant and extended-spectrum β-lactamase-producing Escherichia coli at a comprehensive cancer center in the United States.
Bhusal Y; Mihu CN; Tarrand JJ; Rolston KV
Chemotherapy; 2011; 57(4):335-8. PubMed ID: 21912115
[TBL] [Abstract][Full Text] [Related]
15. Selective culture of Escherichia coli to prevent infective complications of transrectal ultrasound-guided prostate biopsy: Clinical efficacy and analysis of characteristics of quinolone-resistant Escherichia coli.
Hiyama Y; Takahashi S; Uehara T; Ichihara K; Hashimoto J; Matsukawa M; Taguchi K; Kunishima Y; Hotta H; Yanase M; Itoh N; Hirose T; Takeyama K; Tachiki H; Masumori N
Int J Urol; 2019 Jun; 26(6):655-660. PubMed ID: 30959574
[TBL] [Abstract][Full Text] [Related]
16. Characterization of carbapenemases, extended spectrum β-lactamases, quinolone resistance and aminoglycoside resistance determinants in carbapenem-non-susceptible Escherichia coli from a teaching hospital in Chongqing, Southwest China.
Zhang C; Xu X; Pu S; Huang S; Sun J; Yang S; Zhang L
Infect Genet Evol; 2014 Oct; 27():271-6. PubMed ID: 25107431
[TBL] [Abstract][Full Text] [Related]
17. Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy.
Taylor S; Margolick J; Abughosh Z; Goldenberg SL; Lange D; Bowie WR; Bell R; Roscoe D; Machan L; Black P
BJU Int; 2013 May; 111(6):946-53. PubMed ID: 23464844
[TBL] [Abstract][Full Text] [Related]
18. Escherichia coli bloodstream infection after transrectal ultrasound-guided prostate biopsy: implications of fluoroquinolone-resistant sequence type 131 as a major causative pathogen.
Williamson DA; Roberts SA; Paterson DL; Sidjabat H; Silvey A; Masters J; Rice M; Freeman JT
Clin Infect Dis; 2012 May; 54(10):1406-12. PubMed ID: 22419681
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.
Calbo E; Romaní V; Xercavins M; Gómez L; Vidal CG; Quintana S; Vila J; Garau J
J Antimicrob Chemother; 2006 Apr; 57(4):780-3. PubMed ID: 16492721
[TBL] [Abstract][Full Text] [Related]
20. Occurrence of infection following prostate biopsy procedures in Japan: Japanese Research Group for Urinary Tract Infection (JRGU) - a multi-center retrospective study.
Togo Y; Kubo T; Taoka R; Hiyama Y; Uehara T; Hashimoto J; Kurimura Y; Takahashi S; Tsukamoto T; Miyazaki J; Nishiyama H; Kira S; Kiyota H; Yazawa S; Niwa N; Hongo H; Oya M; Kato T; Yasuda M; Deguchi T; Ishikawa K; Hoshinaga K; Matsumoto M; Shigemura K; Tanaka K; Arakawa S; Fujisawa M; Wada K; Uehara S; Watanabe T; Kumon H; Kobayashi K; Matsubara A; Matsumoto M; Sho T; Hamasuna R; Matsumoto T; Hayami H; Nakagawa M; Yamamoto S
J Infect Chemother; 2014 Apr; 20(4):232-7. PubMed ID: 24594451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
